Mutation analysis of factor VIII in Korean patients with severe hemophilia A

被引:7
作者
You, Chur-Woo [5 ]
Son, Hee-Sook [5 ]
Kim, Hee Jin [4 ]
Woo, Eui-Jeon [3 ]
Kim, Soon-Ae [2 ]
Baik, Haing-Woon [1 ]
机构
[1] Eulji Univ, Sch Med, Dept Biochem & Mol Biol, Taejon 301832, South Korea
[2] Eulji Univ, Sch Med, Dept Pharmacol, Taejon 301832, South Korea
[3] Korea Res Inst Biosci & Biotechnol, Translat Res Ctr, Taejon, South Korea
[4] Sungkyunkwan Univ, Sch Med, Dept Lab Med, Seoul, South Korea
[5] Eulji Univ, Sch Med, Dept Pediat, Taejon 301832, South Korea
关键词
Severe hemophilia A; Korean; Factor VIII; Mutation; INHIBITOR DEVELOPMENT; INVERSION HOTSPOT; MOLECULAR-BASIS; GENE; IDENTIFICATION; SITE; POLYMORPHISMS; RECOMBINANT; DIAGNOSIS; RESIDUES;
D O I
10.1007/s12185-010-0593-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemophilia A is an X-linked recessive disorder caused by mutations of the factor VIII gene. The mutation spectrum has been reported in various populations, but not in Koreans. Mutation analysis of the factor VIII gene was performed in 22 unrelated Korean patients with severe hemophilia A. We extracted genomic DNA from their blood, and assessed intron inversions, deletions, and point mutations by direct DNA sequencing. A multiplex ligation-dependent probe amplification gene dosage assay was also performed to identify exon deletions. Disease-causing mutations were identified in all patients, of which four cases were previously unreported. Seven intron 22 inversions, nine point mutations (6 nonsense mutations and 3 missense mutations), and four small rearrangements were identified. One multi-exon deletion and one 5'-donor splicing site mutation were also observed. Four novel mutations (one small deletion, one multiple exon deletion, one missense, and one splice site mutation) were detected, and point mutations were predominant (40.9%), followed by intron 22 inversions (31.8%). Further studies are required in order to establish a solid conclusion regarding the prevalence of various mutations in the Korean population.
引用
收藏
页码:784 / 791
页数:8
相关论文
共 50 条
  • [31] Frequency of intron 1 and 22 inversions of factor VIII gene in Mexican patients with severe hemophilia A
    Milena Mantilla-Capacho, Johanna
    Patricia Beltran-Miranda, Claudia
    Luna-Zaizar, Hilda
    Aguilar-Lopez, Lilia
    Amparo Esparza-Flores, Maria
    Lopez-Guido, Beatriz
    Troyo-Sanroman, Rogelio
    Rebeca Jaloma-Cruz, Ana
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (04) : 283 - 287
  • [32] Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A
    Bachelet, Delphine
    Albert, Thilo
    Mbogning, Cyprien
    Hassler, Signe
    Zhang, Yuan
    Schultze-Strasser, Stephan
    Repesse, Yohann
    Rayes, Julie
    Pavlova, Anna
    Pezeshkpoor, Behnaz
    Liphardt, Kerstin
    Davidson, Julie E.
    Hincelin-Mery, Agnes
    Donnes, Pierre
    Lacroix-Desmazes, Sebastien
    Konigs, Christoph
    Oldenburg, Johannes
    Broet, Philippe
    Deisenhammer, Florian
    Christodoulou, Louis
    Sikkema, Dan
    Loercher, Amy
    Davidson, Julie
    Lawton, Andy
    Etheridge, Steve
    Miles, Sally
    Pallardy, Marc
    Tourdot, Sophie
    Mariette, Xavier
    El-Hamdi, Nadia
    De Vries, Niek
    Musters, Anne
    Doublet, Aline
    Allez, Matthieu
    Williams, Sabrina
    Hahn, Anna Fogdell
    Ryner, Malin
    Ramanujam, Ryan
    Hickling, Tim
    Bertotti, Elisa
    Le Grand, Julie
    Mauri, Claudia
    Jury, Liz
    Mikol, Vincent
    Prades, Catherine
    Loas, Pauline
    Maggi, Enrico
    Karle, Annette
    Spindeldreher, Sebastian
    Romach-Riegraf, Verena
    PLOS ONE, 2019, 14 (06):
  • [33] Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
    Eckhardt, Corien L.
    van Velzen, Alice S.
    Peters, Marjolein
    Astermark, Jan
    Brons, Paul P.
    Castaman, Giancarlo
    Cnossen, Marjon H.
    Dors, Natasja
    Escuriola-Ettingshausen, Carmen
    Hamulyak, Karly
    Hart, Daniel P.
    Hay, Charles R. M.
    Haya, Saturnino
    van Heerde, Waander L.
    Hermans, Cedric
    Holmstrom, Margareta
    Jimenez-Yuste, Victor
    Keenan, Russell D.
    Klamroth, Robert
    Laros-van Gorkom, Britta A. P.
    Leebeek, Frank W. G.
    Liesner, Ri
    Makipernaa, Anne
    Male, Christoph
    Mauser-Bunschoten, Evelien
    Mazzucconi, Maria G.
    Mcrae, Simon
    Meijer, Karina
    Mitchell, Michael
    Morfini, Massimo
    Nijziel, Marten
    Oldenburg, Johannes
    Peerlinck, Kathelijne
    Petrini, Pia
    Platokouki, Helena
    Reitter-Pfoertner, Sylvia E.
    Santagostino, Elena
    Schinco, Piercarla
    Smiers, Frans J.
    Siegmund, Berthold
    Tagliaferri, Annarita
    Yee, Thynn T.
    Kamphuisen, Pieter Willem
    van der Bom, Johanna G.
    Fijnvandraat, Karin
    BLOOD, 2013, 122 (11) : 1954 - 1962
  • [34] Factor VIII half-life and clinical phenotype of severe hemophilia A
    van Dijk, Karin
    van der Bom, Johanna G.
    Lenting, Peter J.
    de Groot, Philip G.
    Mauser-Bunschoten, Eveline P.
    Roosendaal, Goris
    Grobbee, Diederick E.
    van den Berg, H. Marijke
    HAEMATOLOGICA, 2005, 90 (04) : 494 - 498
  • [35] The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X
    Yada, Koji
    Nogami, Keiji
    Wakabayashi, Hironao
    Fay, Philip J.
    Shima, Midori
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (06) : 1007 - 1015
  • [36] Factor VIII alloantibodies in hemophilia
    Jacquemin, MG
    Saint-Remy, JMR
    CURRENT OPINION IN HEMATOLOGY, 2004, 11 (03) : 146 - 150
  • [37] von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A Patients
    van Moort, Iris
    Bukkems, Laura H.
    Heijdra, Jessica M.
    Schutgens, Roger E. G.
    Laros-van Gorkom, Britta A. P.
    Nieuwenhuizen, Laurens
    van der Meer, Felix J. M.
    Fijnvandraat, Karin
    Ypma, Paula
    de Maat, Moniek P. M.
    Leebeek, FrankW. G.
    Meijer, Karina
    Eikenboom, Jeroen
    Mathot, Ron A. A.
    Cnossen, Marjon H.
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (07) : 1056 - 1065
  • [38] Antibody response to recombinant human coagulation factor VIII in a new rat model of severe hemophilia A
    Lovgren, K. M.
    Sondergaard, H.
    Skov, S.
    Weldingh, K. N.
    Tranholm, M.
    Wiinberg, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (04) : 747 - 756
  • [39] Frequency of Intron 22 Inversion in Severe Hemophilia A Patients
    Ashfaq, Javeria
    Ahmed, Rehana
    Tariq, Faryal
    ul Abedin, Qurat
    Abid, Madiha
    Borhany, Munira
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [40] Combined analysis of the MspI and XbaI polymorphisms in intron 22 of the factor VIII gene for detection of hemophilia A in a Korean population
    Park, S. H.
    Chung, N.
    Lee, M. R.
    Yoo, S. K.
    Choi, Y. M.
    GENETICS AND MOLECULAR RESEARCH, 2012, 11 (01) : 1 - 9